Panacos Pharmaceuticals, Inc.
PANC
$0.00
$0.000.00%
OTC PK
| 09/30/2008 | 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | |
|---|---|---|---|---|---|
| Net Income | 16.32% | -14.45% | 8.95% | -18.15% | 21.97% |
| Total Depreciation and Amortization | 0.00% | 2.11% | -1.04% | -3.03% | -41.76% |
| Total Amortization of Deferred Charges | 1.87% | 3.38% | 4.02% | 255.36% | 5,500.00% |
| Total Other Non-Cash Items | 0.00% | -9.29% | 36.43% | -36.22% | -59.37% |
| Change in Net Operating Assets | -167.67% | 196.13% | -173.56% | 2,055.71% | 94.95% |
| Cash from Operations | -0.37% | 8.08% | -18.64% | -2.52% | 24.41% |
| Capital Expenditure | 90.32% | 34.04% | -213.33% | -400.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 85.75% | -38.38% | 77.98% | 215.37% | -122.08% |
| Cash from Investing | 88.46% | -38.45% | 76.88% | 214.22% | -122.12% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -861.48% | -3.05% | -773.33% | 76.92% | 67.82% |
| Issuance of Common Stock | -100.00% | 850.00% | -80.00% | -41.18% | -98.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 80.58% |
| Cash from Financing | -1,018.97% | 10.08% | -101.25% | 10,250.00% | -100.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.67% | -10.54% | -204.73% | 158.54% | -201.67% |